182 related articles for article (PubMed ID: 10166356)
1. Evaluation of DRI enzyme immunoassays for drugs-of-abuse screening on the Cobas Mira.
Broussard LA; Hanson L
Clin Lab Sci; 1997; 10(2):83-6. PubMed ID: 10166356
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the MTP immunoassay with EMIT in blood screening for drugs].
Käferstein H; Sticht G
Arch Kriminol; 1998; 202(5-6):165-72. PubMed ID: 10023491
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Abuscreen ONLINE assay for amphetamines on the Hitachi 737: comparison with EMIT and GC/MS methods.
Baker DP; Murphy MS; Shepp PF; Royo VR; Caldarone ME; Escoto B; Salamone SJ
J Forensic Sci; 1995 Jan; 40(1):108-12. PubMed ID: 7876791
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.
Stout PR; Klette KL; Horn CK
J Forensic Sci; 2004 Jan; 49(1):160-4. PubMed ID: 14979364
[TBL] [Abstract][Full Text] [Related]
5. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
Lu NT; Taylor BG
Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
[TBL] [Abstract][Full Text] [Related]
6. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
[TBL] [Abstract][Full Text] [Related]
7. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood.
Hino Y; Ojanperä I; Rasanen I; Vuori E
Forensic Sci Int; 2003 Jan; 131(2-3):148-55. PubMed ID: 12590054
[TBL] [Abstract][Full Text] [Related]
8. CEDIA for screening drugs of abuse in urine and the effect of adulterants.
Wu AH; Forte E; Casella G; Sun K; Hemphill G; Foery R; Schanzenbach H
J Forensic Sci; 1995 Jul; 40(4):614-8. PubMed ID: 7595298
[TBL] [Abstract][Full Text] [Related]
9. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
[TBL] [Abstract][Full Text] [Related]
10. Modification and evaluation of Abuscreen OnLine assays for drug metabolites in urine performed on a COBAS FARA II in comparison with EMIT d.a.u. Cannabinoid 20.
Hailer M; Glienke Y; Schwab IM; von Meyer L
J Anal Toxicol; 1995; 19(2):99-103. PubMed ID: 7769796
[TBL] [Abstract][Full Text] [Related]
11. Determination of opiates and cocaine in hair using automated enzyme immunoassay screening methodologies followed by gas chromatographic-mass spectrometric (GC-MS) confirmation.
Lachenmeier K; Musshoff F; Madea B
Forensic Sci Int; 2006 Jun; 159(2-3):189-99. PubMed ID: 16203118
[TBL] [Abstract][Full Text] [Related]
12. Method comparison of EMIT II and online with RIA for drug screening.
Armbruster DA; Schwarzhoff RH; Pierce BL; Hubster EC
J Forensic Sci; 1993 Nov; 38(6):1326-41. PubMed ID: 8263477
[TBL] [Abstract][Full Text] [Related]
13. Substance abuse testing of urine by GC/MS in scanning mode evaluated by proficiency studies, TLC/GC, and EMIT.
Gibb RP; Cockerham H; Goldfogel GA; Lawson GM; Raisys VA
J Forensic Sci; 1993 Jan; 38(1):124-33. PubMed ID: 8381160
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair.
Pujol ML; Cirimele V; Tritsch PJ; Villain M; Kintz P
Forensic Sci Int; 2007 Aug; 170(2-3):189-92. PubMed ID: 17628371
[TBL] [Abstract][Full Text] [Related]
15. Urinary amphetamines, benzodiazepines and methadone: cost-effective detection procedures.
Moore FM; Jarvie DR; Simpson D
Med Lab Sci; 1992 Mar; 49(1):27-33. PubMed ID: 1453905
[TBL] [Abstract][Full Text] [Related]
16. European multicentre evaluation of the analytical performance of the Abbott AxSYM Abused Drugs Assays.
von Meyer L; Hänseler E; Lardet G; Scholer A; Sieghart W
Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):133-40. PubMed ID: 9056758
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the triage system for emergency drugs-of-abuse testing in urine.
Wu AH; Wong SS; Johnson KG; Callies J; Shu DX; Dunn WE; Wong SH
J Anal Toxicol; 1993; 17(4):241-5. PubMed ID: 8371556
[TBL] [Abstract][Full Text] [Related]
18. Phencyclidine and cannabinoids in vitreous humor.
Jenkins AJ; Oblock J
Leg Med (Tokyo); 2008 Jul; 10(4):201-3. PubMed ID: 18294895
[TBL] [Abstract][Full Text] [Related]
19. Clinical issues associated with urine testing of substances of abuse.
Eskridge KD; Guthrie SK
Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
[TBL] [Abstract][Full Text] [Related]
20. Lack of cross-reactivity of Ambien (zolpidem) with drugs in standard urine drug screens.
Piergies AA; Sainati S; Roth-Schechter B
Arch Pathol Lab Med; 1997 Apr; 121(4):392-4. PubMed ID: 9140309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
